Last reviewed · How we verify

NCT03587246

Comparison of Uterine Peristaltic Wave Frequencies Between Pregnant and Non-pregnant Women in Embryo Transfer Cycles

Completed Last updated 21 March 2019
What this trial tests

trial testing 3DTVUS : Uterine peristaltic frequencies in Uterine Peristaltic Frequencies Between Pregnant and Non-pregnant Women in Embryo Transfer Cycles in 184 participants. Completed in 30 December 2018.

Timeline
26 July 2018
Primary endpoint
30 December 2018
30 December 2018

Quick facts

Lead sponsorChulalongkorn University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment184
Start date26 July 2018
Primary completion30 December 2018
Estimated completion30 December 2018
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Chulalongkorn University

Who can join

Under 45, female only, with Uterine Peristaltic Frequencies Between Pregnant and Non-pregnant Women in Embryo Transfer Cycles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Eligibility criteria * Infertile woemn undergo IVF \& embryo transfer cycles at infertility clinic at King Chulalongkorn Memorial Hospital Measurement * Uterine peristaltic wave frequencies \& Junctional zone thickness by 3D-TVUS on the day of oocyte retrieval in fresh embryo transfer participants \& day before progesterone supplementation in frozen-thawed embryo transfer participants * Serum progesterone \& estradiol level in the same day

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Chulalongkorn University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03587246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing